Pharmaceutical Technology Europe
So could the online auction formula be extended to the pharmaceutical industry? It might be a great way to make some big savings.
Online shopping has become something of a phenomenon during the past decade. Why bother trawling through shops when you can order just about anything online — you don't even have to leave the comfort of your own seat, let alone the house. A few clicks and it's completed. OK, so your purchase may take a couple of days longer to arrive compared with going to a shop, but the savings far outweigh the delay. And besides, it's always nicer and much more exciting to get parcels through the post.
Gurminder Marwaha
I am happy to admit that I do most of my shopping online — a favourite is grocery shopping. Not that it gives me any pleasure; far from it. But, it's a lot easier than going to a supermarket full of screaming kids, unhelpful staff and coming out with 'beep beep beep' from the tills ringing in your ears. It takes less than 30 minutes to do a weekly shop online and they deliver right to my door. Perfect.
One of the best things to happen to online shopping has been web-based auction sites. There's something for everyone on these, and if you're quick enough you can grab an absolute bargain. But they have become more than just online auction houses; they are now proper market places, fully fledged institutions.
So could the online auction formula be extended to the pharmaceutical industry? For me, the customer should always come first and this would be a great way to make some big savings. Vendors needn't worry either — the auction process would help the best vendors make some good money. Something for everyone then!
Of course, the reality is that this would never happen. The market may witness cheap imitations and rip off merchants — though judging by some comments that I have heard recently, this is happening to a degree anyway. I guess the regulatory authorities wouldn't be too pleased either.
It's a shame really, because it would be quite exciting to watch pharmaceutical companies from across the globe battling it out to find the cheapest raw materials and process equipment. The serious point is that it would certainly bring our heavily fragmented industry much closer together — it would also be a lot more fun, and that never hurts anybody.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
FDA Approves Novartis Oral Treatment for Adults with C3 Glomerulopathy
March 25th 2025Fabhalta (iptacopan) received a positive opinion for treatment of C3G from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) and has been approved twice before by FDA.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.